Details werden geladen...
Moderna and Merck Announce Positive Phase 3 Results for Melanoma Vaccine
mRNA melanoma vaccine: Moderna and Merck announce positive results from the Phase 3 trial of INTerpath-001. Reduced risk of recurrence and metastasis.
Ähnliche Seiten
Moderna, Merck mRNA melanoma vaccine succeeds in first late-stage cancer trial
https://www.ynetnews.com/health_science/article/hk31gm7dfx
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.brisbanetimes.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.smh.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.theage.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.watoday.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed